Using the genomic adjusted radiation dose (GARD) to personalize the radiation dose in nasopharyngeal cancer.
Chiang CL, Chan KSK, Li H, Ng WT, Chow JCH, Choi HCW, Lam KO, Lee VHF, Ngan RKC, Lee AWM, Eschrich SA, Torres-Roca JF, Wong JWH.
Chiang CL, et al.
Radiother Oncol. 2024 Jul;196:110287. doi: 10.1016/j.radonc.2024.110287. Epub 2024 Apr 16.
Radiother Oncol. 2024.
PMID: 38636709
Clinical Trial.